Urinary concentration: different ways to open and close the tap. (Q38111968)

29 August 2017

0 references

Urinary concentration: different ways to open and close the tap. (English)

1 reference

29 August 2017

Detlef Bockenhauer

1

1 reference

PubMed ID

23736674

29 August 2017

Daniel G Bichet

series ordinal

2

1 reference

29 August 2017

6 June 2013

1 reference

29 August 2017

1 reference

29 August 2017

29

1 reference

29 August 2017

8

1 reference

29 August 2017

1297-1303

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-013-2526-4

29 August 2017

0 references

cites work

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Cloning and expression of apical membrane water channel of rat kidney collecting tubule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

21 January 2018

Vasopressin antagonists

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

The kidney speaks: interpreting urinary sodium and osmolality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Osmosensation in vasopressin neurons: changing actin density to optimize function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Water intake and the neural correlates of the consciousness of thirst

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Aquaporins in the kidney: from molecules to medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Vasopressin receptor-mediated functional signaling pathway in primary cilia of renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Bardet–Biedl syndrome highlights the major role of the primary cilium in efficient water reabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Antenatal Bartter's syndrome: why is this not a lethal condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Secondary nephrogenic diabetes insipidus as a complication of inherited renal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Inherited secondary nephrogenic diabetes insipidus: concentrating on humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Does a high concentration of calcium in the urine cause an important renal concentrating defect in human subjects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Secretin stimulates cyclic AMP and inositol trisphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Phenotypes developed in secretin receptor-null mice indicated a role for secretin in regulating renal water reabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Vasopressin-independent mechanisms in controlling water homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Genetic ablation of aquaporin-2 in the mouse connecting tubules results in defective renal water handling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Vasopressin-prostaglandin interactions in the regulation of epithelial cell permeability to water

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Prostaglandins and water metabolism: A review with emphasis on in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Vasopressin Type 2 Receptor V88M Mutation: Molecular Basis of Partial and Complete Nephrogenic Diabetes Insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Role of prostaglandins in the regulation of renal water excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Effect of prostaglandins on renal epithelial electrolyte transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Nephrogenic diabetes insipidus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Actin remodeling requires ERM function to facilitate AQP2 apical targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Chlorothiazid in Diabetes Insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2526-4

Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus

21 January 2018

1 reference

12 December 2020

Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus

1 reference

12 December 2020

The effect of inhibition of prostaglandin synthesis on free water and osmolar clearances in patients with hereditary nephrogenic diabetes insipidus

1 reference

12 December 2020

Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus

1 reference

12 December 2020

Rolipram, a phosphodiesterase inhibitor, in the treatment of two male patients with congenital nephrogenic diabetes insipidus

1 reference

12 December 2020

Treatment of diabetes insipidus with hydrochlorothiazide

1 reference

12 December 2020

Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype.

1 reference

12 December 2020

Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings.

1 reference

12 December 2020

Nephrogenic diabetes insipidus; transmitted by females and appearing during infancy in males

1 reference

12 December 2020

A patient with polyuria and hydronephrosis: question

1 reference

12 December 2020

Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus

1 reference

12 December 2020

Renal prostaglandin E2 in nephrogenic diabetes insipidus: effects of inhibition of prostaglandin synthesis by indomethacin

1 reference

12 December 2020

Renal concentrating and diluting function in deficiency of specific aquaporin genes

1 reference

12 December 2020

10.1007/S00467-013-2526-4

Identifiers

DOI

1 reference

PubMed ID

23736674

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

23736674